Arcadia’s EHR-derived longitudinal data and clinical notes expand visibility into patient journeys

PHILADELPHIA, PA — HealthVerity, the leader in privacy-protected real-world data exchange and patient identity solutions, today announced that Arcadia has been named as one of the data sources available in HealthVerity Marketplace, the nation’s largest ecosystem of privacy-protected healthcare and consumer data. Arcadia will be offering clinically-grounded, longitudinal patient data that strengthens the real-world data ecosystem by enabling life sciences and commercial analytics teams to conduct more informed research, outcomes analysis and commercial decision-making.

HealthVerity Marketplace already connects the industry’s most comprehensive network of data providers and buyers in a HIPAA-compliant and privacy-protected platform. With Arcadia, customers benefit from greater transparency into data provenance while continuing to work within a governed, interoperable environment.

Arcadia brings clinically-grounded, EHR-derived longitudinal data from the Arcadia Research Collaborative to HealthVerity Marketplace, enabling patient-level analysis across care settings with visibility into real-world clinical events and provider interactions. This foundation is further enriched with clinical notes processed through natural language processing, unlocking insights beyond structured data and coded fields. Adjudicated closed claims data complements this dataset, providing additional context on utilization and cost. Together, these de-identified data assets support a more complete view of patient journeys for real-world evidence, health economics and outcomes research (HEOR) and commercial analytics.

“Adding Arcadia to HealthVerity Marketplace gives researchers and analytics teams access to clinically grounded longitudinal data within the workflows they already use. It’s another step toward making high-quality real-world data easier to discover, evaluate and use,” said Joseph Satili, Chief Commercial Officer, HealthVerity.

“Life sciences organizations have long relied on claims data to understand patient populations, but claims tell us what happened, not why it happened or how patients actually experience their disease. That view is inherently incomplete,” said Sandy Leonard, General Manager, Life Sciences, Arcadia. “By bringing EHR-derived clinical data and unstructured clinical notes into HealthVerity Marketplace, Arcadia enables a more nuanced, longitudinal understanding of patient journeys—revealing the clinical context, decision points and lived experience behind the data.”

To learn more or request access, please explore HealthVerity Marketplace or contact your HealthVerity representative. Interested organizations can also visit Arcadia at ISPOR booth 913 and HealthVerity at booth 1004 from May 17-20, 2026 in Philadelphia, Pennsylvania.

About HealthVerity

HealthVerity is the leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data. By enabling access to the industry’s largest RWD ecosystem, HealthVerity supports critical applications in clinical development, commercial strategy, regulatory decision-making and public health.

Media Contact:

HealthVerity
info@healthverity.com

About Arcadia

Arcadia® is an outcomes company that helps healthcare organizations improve cost, quality, and operational performance. We close the gap between insight and aligned action by unifying healthcare data and translating it into execution through workflow tools embedded with agentic AI. Built on a comprehensive data foundation spanning tens of millions of patient lives, Arcadia supports hundreds of organizations, including Aetna, Highmark Blue Cross Blue Shield, Merck, and the California Department of Health Care Services.

Media Contact:

Drew Schaar, Arcadia
Drew.Schaar@arcadia.io

Philadelphia, PA, — HealthVerity, the leader in privacy-protected real-world data exchange and patient identity solutions, today announced the successful completion of its previously announced agreement to acquire Symphony Health Solutions Corporation, a commercial healthcare data business formerly part of ICON plc (NASDAQ: ICLR).

The transaction will define the next era of healthcare real-world data by bringing together HealthVerity’s clinical data depth and experience with Symphony Health’s commercial insights and scale into a single, connected view of patients and providers – backed by 40 years of combined experience.

Healthcare data has long been fragmented with separate sources providing different commercial and clinical data, analytics and technical capabilities, each requiring its own contract, integration and reconciliation. Organizations operating across life sciences, government, payers and analytics have been forced to stitch together disconnected datasets, often working from an incomplete and inconsistent view of the patient and provider.

HealthVerity’s acquisition of Symphony Health is designed to solve that problem at its core.

“With the Symphony Health acquisition, our focus turns to executing with speed and discipline as we usher in an era of unprecedented access to patient-centric data with the depth and breadth capable of driving the next generation of insights and analytics,” said Andrew Kress, Chief Executive Officer of HealthVerity. “Now the real work begins to help drive our clients to a higher level of success.”

The combined offerings will deliver the industry’s most comprehensive and scalable healthcare data solutions, eliminating the tradeoffs between data coverage, depth and usability that have historically limited the market. With deeper insights and more flexibility than legacy or single-source approaches, customers can reduce complexity and accelerate healthcare innovation and breakthroughs.

Evercore served as financial advisor and Blank Rome LLP served as legal advisor to HealthVerity.

About HealthVerity

HealthVerity is the leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data. By enabling access to the industry’s largest RWD ecosystem, HealthVerity supports critical applications in clinical development, commercial strategy, regulatory decision-making and public health.

MEDIA CONTACT
Andrew Goldberg
COO, HealthVerity
info@healthverity.com

Philadelphia, PA, — HealthVerity, Inc., the leader in privacy-protected real-world data exchange and patient identity solutions, today announced that it has entered into a definitive agreement to acquire Symphony Health Solutions Corporation, a commercial healthcare data business formerly part of ICON plc (NASDAQ: ICLR). The transaction is subject to customary closing conditions and is expected to close in May 2026.

The transaction will define the next era of healthcare real-world data by bringing together HealthVerity’s clinical data depth and experience with Symphony Health’s commercial insights and scale into a single, connected view of the patient and providers – backed by 40 years of combined experience.

Healthcare data has long been fragmented with separate sources providing different commercial and clinical data, analytics and technical capabilities, each requiring its own contract, integration and reconciliation. Organizations operating across life sciences, government, payers and analytics have been forced to stitch together disconnected datasets, often working from an incomplete and inconsistent view of the patient and provider.

HealthVerity’s acquisition of Symphony Health is designed to solve that problem at its core.

“This transaction will create the nation’s leading patient-centric real-world and commercial data ecosystem within a privacy-safe, modern infrastructure,” said Andrew Kress, Chief Executive Officer of HealthVerity. “This will allow us to rapidly innovate in developing the next generation of real-world data and applications, giving organizations across the healthcare ecosystem more dynamic and actionable insights to make better and faster decisions.”

“For more than 30 years, Symphony Health has been a trusted source of commercial healthcare data,” said Simon Holmes, President, Corporate Investments & Partnerships at ICON. “Symphony will bring this scale and expertise to the combination with HealthVerity. We look forward to collaborating with the combined business to deliver valuable insights to our customers.”

The combined offerings will deliver the industry’s most comprehensive and scalable healthcare data solutions, eliminating the tradeoffs between data coverage, depth and usability that have historically limited the market. With deeper insights and more flexibility than legacy or single-source approaches, customers can reduce complexity and accelerate healthcare innovation and breakthroughs.

Evercore is serving as financial advisor and Blank Rome LLP is serving as legal advisor to HealthVerity.

About HealthVerity

HealthVerity is the leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data. By enabling access to the industry’s largest RWD ecosystem, HealthVerity supports critical applications in clinical development, commercial strategy, regulatory decision-making and public health.

MEDIA CONTACT
Andrew Goldberg
COO, HealthVerity
info@healthverity.com

Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD) marketplace, to enhance data-driven clinical development and evidence generation for biopharma sponsors.

Through the agreement, Thermo Fisher’s PPD™ clinical research business will gain enterprise-level access to the HealthVerity taXOnomy^® claims dataset, representing more than 270 million de-identified patient lives across the U.S. healthcare system.

The datasets will provide deep insights into disease prevalence, treatment patterns and provider activity, further strengthening the clinical research business’ data and AI driven services across trial feasibility and optimization, recruitment and real-world evidence generation. The agreement also provides access to a marketplace of more than 70 curated data sources, including electronic medical records, laboratory results and other specialty datasets. With streamlined access to longitudinal claims and linked datasets, the business can deliver more precise site selection strategies and improved startup timelines.

“This collaboration advances our ability to integrate high-quality, linked healthcare data into clinical development,” said Krishna Cheriath, vice president, head of clinical research digital and AI, biopharma services, Thermo Fisher Scientific. “By utilizing one of the largest integrated healthcare data ecosystems with our AI-enabled analytics, we can generate robust real-world evidence to support our customers across the clinical and post-approval continuum.”

In addition, the collaboration enhances the business’ real-world evidence and health economics and outcomes research (HEOR) offerings across PPD™ CorEvitas™ Clinical Registries and PPD™ Evidera™ solutions, enabling faster analytics and expanded registry-linked claims capabilities.

“We’re proud to support Thermo Fisher’s PPD clinical research business in advancing data-driven clinical development,” said Joseph Satili, chief commercial officer, HealthVerity. “With enterprise access to robust real-world insights, teams can move faster and with greater confidence—from feasibility through evidence generation—improving how studies are designed and executed.”

The collaboration will allow the PPD™ clinical research business to gain increased flexibility to better position the business to deliver differentiated value, while maintaining rigorous privacy protections and data governance standards. It also builds on Thermo Fisher’s continued investment in digital innovation to support smarter, more efficient clinical development and improved patient outcomes.

About HealthVerity

HealthVerity is the leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data. By enabling access to the industry’s largest RWD ecosystem, HealthVerity supports critical applications in clinical development, commercial strategy, regulatory decision-making, and public health.

Media Contact:

HealthVerity
info@healthverity.com

Thermo Fisher Scientific – Nadine Maeser
nadine.maeser@thermofisher.com

ARLINGTON, VA and PHILADELPHIA, PA — The Association of State and Territorial Health Officials (ASTHO) announced today a partnership with Veritas Data Research and HealthVerity that establishes a first-of-its-kind public health data consortium. This novel consortium brings together ASTHO, jurisdictional health departments and private partners united in a shared mission to improve public health outcomes through enhanced data access and quality, and to address long-standing challenges that hinder our nation’s public health data infrastructure.

“There is tremendous opportunity when we connect the strengths of private industry with the mission of public health,” says Joseph Kanter, MD, MPH, ASTHO CEO. “By working together in a structured way, we can close long-standing data gaps and build a stronger, more responsive system for the future.”

The consortium’s central mission is to improve the quality of and access to real-world data and public health data relied upon by a broad range of stakeholders to drive public and population health decisions and understand longitudinal outcomes. State health agencies, providers, payers, researchers, and others rely on this data, which is often difficult to obtain. Through this public-private partnership, members aim to expand access in ways that strengthen communities and support health care and public health systems.

“Our nation and communities need a robust, sustainable model that leverages the capabilities and expertise across both private industry and public health. For too long, there have been challenges in bringing private and public entities together to address the gaps that plague our nation’s public health data and technology infrastructure,” says Jen Layden, MD, PhD, ASTHO senior vice president of population and innovation, and former CDC and state public health leader. “This consortium, by uniting on a common mission and placing governance in the hands of public health, is primed to be a game changer.”

Jurisdictional health departments will gain access to real-world data and technical capabilities and will play a key role in strengthening the quality and availability of critical data. The consortium will initially focus on mortality data, a foundational asset for a variety of use cases.

“This consortium represents an excellent example of public-private partnerships in healthcare,” said Jason LaBonte, CEO at Veritas Data Research. “Under the governance of ASTHO, all state and territorial health agencies can securely pool their data to improve clinical practice and innovation. In return, the agencies can combine their data with national real-world data to power better public health. Veritas is pleased to facilitate these data exchanges using our robust ingestion and delivery platform, and to make appropriate data available to a wider group of stakeholders with use cases pre-approved by the state and territorial health agencies.”

“We are proud to serve as a founding operating partner, applying our expertise in identity resolution and data privacy to solve the ‘linkage’ problem that has long plagued public health,” said Andrew Kress, CEO of HealthVerity. “Through this consortium, we are enabling a standard of data exchange that respects patient privacy while providing a level of clinical truth that will accelerate research and improve the speed of public health interventions.

To support the consortium, ASTHO is creating an advisory network to provide organizations with opportunities to stay informed and offer guidance as the initiative evolves. To learn more about the consortium or advisory network, please contact phdc@astho.org

About ASTHO

ASTHO is the national nonprofit organization representing the public health agencies of the United States, the U.S. territories and freely associated states, and Washington, D.C., as well as the more than 100,000 public health professionals these agencies employ. ASTHO members, the chief health officials of these jurisdictions, are dedicated to formulating and influencing sound public health policy and to ensuring excellence in public health practice.

About HealthVerity

HealthVerity is the leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data. By enabling access to the industry’s largest RWD ecosystem, HealthVerity supports critical applications in clinical development, commercial strategy, regulatory decision-making, and public health.

Media Contact:

HealthVerity
info@healthverity.com

About Veritas

Founded by experts in the data analytics industry, Veritas combines cutting-edge technology and efficient workflow design to close critical gaps in healthcare data. Specializing in high-fidelity mortality and provider affiliation datasets, Veritas provides secure, integrated tools for both research and operational use. By transforming raw data into actionable insights, Veritas is building next-generation vital status monitoring and tracking solutions to power enhanced patient engagement. To learn more about Veritas, visit  veritasdataresearch.com  and follow on  LinkedIn.

Philadelphia, PA — HealthVerity today announced the appointment of Adam Greenfield as Chief Technology Officer, a role central to defining the company’s technology strategy and ensuring the platforms that power trusted data exchange continue to scale securely and reliably.

As CTO, Greenfield is responsible for aligning engineering, infrastructure, data delivery and security with the company’s business priorities. He will lead the teams that build, operate, and secure critical technology platforms, ensuring that they support scale, reliability, and regulatory compliance for customers across the healthcare ecosystem.

Greenfield brings deep technology leadership experience across healthcare technology organizations. Prior to his appointment as CTO, he served as Vice President of Infrastructure at HealthVerity, where he led the modernization and optimization of the company’s cloud and platform foundations. Before joining HealthVerity, Greenfield served as Chief Technology Officer at Zipari, where he led engineering and platform strategy for healthcare payer solutions. He is known for strengthening collaboration across engineering teams, modernizing technology foundations, and raising the bar for technical excellence as organizations scale.

“As we enter the next phase of the business, clear technical leadership will be critical to driving innovation, accelerating execution, and strengthening collaboration across the R&D team,” said Andrew Kress, CEO of HealthVerity. “Adam is well positioned to lead that effort, working closely with leadership across the business to support business priorities and continue raising the bar for technical excellence.”

“I am excited to step into the CTO role at a pivotal moment for HealthVerity,” said Greenfield. “The company has built a strong technology foundation and I look forward to partnering with the engineering, product, and security teams to continue building scalable, secure platforms that enable trusted data exchange to support our customers’ most critical use cases.”

Learn more about HealthVerity and its leadership team at healthverity.com/about-us

About HealthVerity

HealthVerity is the leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data. By enabling access to the industry’s largest RWD ecosystem, HealthVerity supports critical applications in clinical development, commercial strategy, regulatory decision-making, and public health.

Media Contact:

HealthVerity
info@healthverity.com

PHILADELPHIA, PA, and SOUTH SAN FRANCISCO, CA – HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, and Claritas Rx, the patient journey experts, announced today a strategic partnership to deliver a new data-driven offering that enhances commercial visibility and real-world evidence generation across the pharmaceutical product lifecycle.

The collaboration unites expansive de-identified RWD—including medical and pharmacy claims, EMR, and lab data—from HealthVerity with deeply specialized data on specialty pharmacy (SP), hub, and co-pay programs from Claritas Rx. Together, the companies aim to provide pharmaceutical manufacturers with an integrated, privacy-protected dataset that offers unmatched insight into treatment access, speed-to-therapy, and patient adherence.

For commercial teams, this means a clearer view of brand performance, optimized targeting, and better-informed access strategy decisions. For RWE and HEOR leaders, the offering supports faster, more precise evidence generation by filling critical gaps in the patient journey and enabling longitudinal analysis from prescription to outcome.

“Pharmaceutical companies are under increasing pressure to demonstrate access, effectiveness, and value with real-world data. This partnership gives our clients the depth and flexibility they need to do exactly that,” said Andrew Goldberg, COO and co-founder of HealthVerity. “By integrating our Verified data ecosystem with specialty data expertise from Claritas Rx, we can deliver greater coverage, precision, and stability—key pillars for real-time decision-making.”

“We’re thrilled to work with HealthVerity to meet the growing demand for integrated, actionable patient data,” said Michael Fitzgibbons, CEO of Claritas Rx. “Combining our specialty data insights with HealthVerity’s scalable infrastructure gives commercial, RWE and HEOR teams a powerful 360-degree view into unique patient behavior and treatment dynamics.”

The partnership enables a faster path for pharma customers using the Claritas Rx specialty aggregation platform and analytics to link its aggregated specialty pharmacy/hub/co-pay data with HealthVerity research-grade RWD. Beneficiaries include brand and commercial strategy teams, HEOR teams, and RWE researchers across top life sciences companies. 

Learn more about the partnership or explore the data offering here.

About HealthVerity

HealthVerity is the leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data. By enabling access to the industry’s largest RWD ecosystem, HealthVerity supports critical applications in clinical development, commercial strategy, regulatory decision-making, and public health.

Media Contact:

HealthVerity
info@healthverity.com

About Claritas Rx

Based in South San Francisco, CA, Claritas Rx helps rare disease and specialty brands remove the barriers that keep patients from accessing and staying on the treatments they need. By uniting the most complete view of the patient journey with purpose-built technologies, we predict and resolve access challenges before they disrupt care. Our intelligent solutions combine advanced analytics, real-world data, AI, and in-line CRM capabilities to increase start and refill rates, reduce abandonment, and improve brand performance. For more information, visit www.ClaritasRx.com.

Media Contact:

Claritas Rx
ebrennan@claritasrx.com

PHILADELPHIA, PA – HealthVerity, the leader in real-world data (RWD) technologies and privacy-compliant data exchange, today announced the launch of taXonomy Pathways, a groundbreaking framework that unites closed payer claims, lab results and electronic health records (EHR), including physician notes into research-ready therapeutic area-specific datasets designed to close critical evidence gaps across life sciences, payers, government and consulting partners.

Therapeutic areas from taXonomy Pathways are anchored by the nation’s largest source of closed payer claims, spanning hundreds of payers, nine years of adjudicated history and more than 300 million patients across all pay types. The acclaimed taXonomy data model synthesizes multi-payer medical and pharmacy claims and eligibility into a streamlined relational dataset that enables efficient ingestion and onboarding. Teams are able to get up to speed quickly and translate study protocols to valuable analysis . Further innovation comes from expanding beyond claims into novel patient features that are only available from lab results and EHR, including physician notes, that fundamentally enrich the patient journey.

In diabetes and obesity cohorts, repeated measures such as BMI, HbA1c, weight, blood pressure and lipid panels provide a comprehensive view of disease progression and treatment response. For heart failure, echocardiogram‑derived left‑ventricular ejection fraction and cardiovascular labs illuminate cardiac function, guideline‑directed therapy uptake and hospitalisation risk. In oncology, lab results confirm diagnosis and provide prognostic insight essential for precision medicine, while for neurology and rare diseases, structured EMR and clinical notes reveal symptom‑level detail, adverse events and real‑world outcomes that claims cannot capture.

“With taXonomy Pathways, we are simplifying the assembly of longitudinal patient journeys” said Andrew Kress, CEO of HealthVerity. “Now, researchers can seamlessly access claims, EHR, labs and clinical notes in a single, research-ready framework that accelerates time to evidence without compromising rigor, privacy or scale. This is a game-changer for real-world evidence, safety and beyond.”

taXonomy Pathways includes lab results from two leading outpatient labs, representing more than 60% of U.S. testing, including genetic assays. Lab values and collection dates align with exposure windows from medical and pharmacy claims to derive baselines and quantify treatment response. RWE and HEOR teams can track how often diagnostic tests are followed by treatment and assess test yield by payer and region, giving market access teams evidence to shape coverage policies and provider engagement.

To deepen insights further, taXonomy Pathways incorporates more than 3.6 billion de‑identified clinical notes across 340 million encounters for 43 million patients. These narrative notes capture symptoms, disease severity, imaging results, contraindications and reasons for discontinuation, giving researchers a broader view across therapeutic areas that far exceeds a claims-only approach.

Available now

taXonomy Pathways is available today. For more information, register for our webinar to see how you can close the evidence gap in your therapeutic area or schedule a meeting with our sales team.

About HealthVerity

HealthVerity is the leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data. By enabling access to the industry’s largest RWD ecosystem, HealthVerity supports critical applications in clinical development, commercial strategy, regulatory decision-making, and public health.

Media Contact:

HealthVerity
info@healthverity.com